Priyanka Rohatgi, a GCV Rising Stars award winner, has joined Denmark-based Novo, a private healthcare company fully owned by the Novo Nordisk Foundation, as a partner in its corporate venturing unit.
She had previously spent about a year as a venture partner at Longwood Fund with a board observer role at Interius BioTherapeutics.
This followed more than eight years in corporate venture capital, initially at Baxter Ventures, then AbbVie Ventures and finally Ipsen Ventures.
